The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Subcutaneous Injection Immunoglobulin Market Research Report 2025
Synopsis
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
The global Subcutaneous Injection Immunoglobulin market was valued at US$ 1864 million in 2023 and is anticipated to reach US$ 2786.8 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Injection Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Injection Immunoglobulin.
Report Scope
The Subcutaneous Injection Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Injection Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Injection Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Grifols
CSL
Segment by Type
10% Purity
20% Purity
Segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Subcutaneous Injection Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Subcutaneous Injection Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
The global Subcutaneous Injection Immunoglobulin market was valued at US$ 1864 million in 2023 and is anticipated to reach US$ 2786.8 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Injection Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Injection Immunoglobulin.
Report Scope
The Subcutaneous Injection Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Injection Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Injection Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Grifols
CSL
Segment by Type
10% Purity
20% Purity
Segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Subcutaneous Injection Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Subcutaneous Injection Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Subcutaneous Injection Immunoglobulin Market Overview
1.1 Product Overview and Scope of Subcutaneous Injection Immunoglobulin
1.2 Subcutaneous Injection Immunoglobulin Segment by Type
1.2.1 Global Subcutaneous Injection Immunoglobulin Market Value Comparison by Type (2024-2030)
1.2.2 10% Purity
1.2.3 20% Purity
1.3 Subcutaneous Injection Immunoglobulin Segment by Application
1.3.1 Global Subcutaneous Injection Immunoglobulin Market Value by Application: (2024-2030)
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Global Subcutaneous Injection Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Injection Immunoglobulin Revenue 2019-2030
1.4.2 Global Subcutaneous Injection Immunoglobulin Sales 2019-2030
1.4.3 Global Subcutaneous Injection Immunoglobulin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Subcutaneous Injection Immunoglobulin Market Competition by Manufacturers
2.1 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Subcutaneous Injection Immunoglobulin Average Price by Manufacturers (2019-2024)
2.4 Global Subcutaneous Injection Immunoglobulin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Product Type & Application
2.7 Subcutaneous Injection Immunoglobulin Market Competitive Situation and Trends
2.7.1 Subcutaneous Injection Immunoglobulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Subcutaneous Injection Immunoglobulin Players Market Share by Revenue
2.7.3 Global Subcutaneous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Subcutaneous Injection Immunoglobulin Retrospective Market Scenario by Region
3.1 Global Subcutaneous Injection Immunoglobulin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Subcutaneous Injection Immunoglobulin Global Subcutaneous Injection Immunoglobulin Sales by Region: 2019-2030
3.2.1 Global Subcutaneous Injection Immunoglobulin Sales by Region: 2019-2024
3.2.2 Global Subcutaneous Injection Immunoglobulin Sales by Region: 2025-2030
3.3 Global Subcutaneous Injection Immunoglobulin Global Subcutaneous Injection Immunoglobulin Revenue by Region: 2019-2030
3.3.1 Global Subcutaneous Injection Immunoglobulin Revenue by Region: 2019-2024
3.3.2 Global Subcutaneous Injection Immunoglobulin Revenue by Region: 2025-2030
3.4 North America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country
3.4.1 North America Subcutaneous Injection Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Subcutaneous Injection Immunoglobulin Sales by Country (2019-2030)
3.4.3 North America Subcutaneous Injection Immunoglobulin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Injection Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Subcutaneous Injection Immunoglobulin Sales by Country (2019-2030)
3.5.3 Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country
3.6.1 Asia Pacific Subcutaneous Injection Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Country (2019-2030)
3.6.3 Asia Pacific Subcutaneous Injection Immunoglobulin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Injection Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Subcutaneous Injection Immunoglobulin Sales by Country (2019-2030)
3.7.3 Latin America Subcutaneous Injection Immunoglobulin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Subcutaneous Injection Immunoglobulin Sales by Type (2019-2030)
4.1.1 Global Subcutaneous Injection Immunoglobulin Sales by Type (2019-2024)
4.1.2 Global Subcutaneous Injection Immunoglobulin Sales by Type (2025-2030)
4.1.3 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2019-2030)
4.2 Global Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2030)
4.2.1 Global Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2024)
4.2.2 Global Subcutaneous Injection Immunoglobulin Revenue by Type (2025-2030)
4.2.3 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2019-2030)
4.3 Global Subcutaneous Injection Immunoglobulin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Subcutaneous Injection Immunoglobulin Sales by Application (2019-2030)
5.1.1 Global Subcutaneous Injection Immunoglobulin Sales by Application (2019-2024)
5.1.2 Global Subcutaneous Injection Immunoglobulin Sales by Application (2025-2030)
5.1.3 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2019-2030)
5.2 Global Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2030)
5.2.1 Global Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2024)
5.2.2 Global Subcutaneous Injection Immunoglobulin Revenue by Application (2025-2030)
5.2.3 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2019-2030)
5.3 Global Subcutaneous Injection Immunoglobulin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Subcutaneous Injection Immunoglobulin Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Subcutaneous Injection Immunoglobulin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Subcutaneous Injection Immunoglobulin Product Portfolio
6.3.5 CSL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Injection Immunoglobulin Industry Chain Analysis
7.2 Subcutaneous Injection Immunoglobulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Injection Immunoglobulin Production Mode & Process
7.4 Subcutaneous Injection Immunoglobulin Sales and Marketing
7.4.1 Subcutaneous Injection Immunoglobulin Sales Channels
7.4.2 Subcutaneous Injection Immunoglobulin Distributors
7.5 Subcutaneous Injection Immunoglobulin Customers
8 Subcutaneous Injection Immunoglobulin Market Dynamics
8.1 Subcutaneous Injection Immunoglobulin Industry Trends
8.2 Subcutaneous Injection Immunoglobulin Market Drivers
8.3 Subcutaneous Injection Immunoglobulin Market Challenges
8.4 Subcutaneous Injection Immunoglobulin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
